Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ila-Shruti Gaur"'
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 392(12)
Nonalcoholic fatty liver disease (NAFLD) is regarded as the hepatic manifestation of the metabolic syndrome. It begins with the accumulation of fat in the liver (simple steatosis), which if untreated can progress to nonalcoholic steatohepatitis, cirr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e6d815b4b7c2567c6ecf54eda4d46af
https://pubmed.ncbi.nlm.nih.gov/31372694
https://pubmed.ncbi.nlm.nih.gov/31372694
Autor:
Renuka Munshi, Ila-Shruti Gaur, Sarayu A. Pai, Malvika Gursahani, Archana R. Juvekar, Falguni Panchal, Snehal N. Mestry
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 111, Iss, Pp 686-694 (2019)
Background Chronic consumption of fructose causes obesity and nonalcoholic fatty liver disease (NAFLD). Currently available therapies have limitations; hence there is a need to screen new molecules. Plumbagin is a naphthoquinone present in the roots
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4447bb745e593f790ed3cce4b376c50a
https://pubmed.ncbi.nlm.nih.gov/30611993
https://pubmed.ncbi.nlm.nih.gov/30611993